We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
WCG Clinical
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Sonia R. Peterson
Sonia R. Peterson
Products
PRODUCTS
Natren, Inc.
Sonia R. Peterson
Price:
$117.00
View
Natren, Inc.
Sonia R. Peterson
Price:
$117.00
View
Alfa Wassermann S.p.A.
Sonia R. Peterson
Price:
$117.00
View
Staar Surgical Co.
Donna L. Tartaglino Besone
and
Sonia R. Peterson
Price:
$117.00
View
Cosmetic Technologies, Inc.
Sonia R. Peterson
Price:
$117.00
View
Lifetech Resources, LLC
Sonia R. Peterson
Price:
$117.00
View
Creation's Garden Natural Products, Inc.
Rocio Guzman-Velazquez
,
Maxyne Lam
, and
Sonia R. Peterson
Price:
$117.00
View
PureTek Corp.
Uttaniti Limchumroon
and
Sonia R. Peterson
Price:
$117.00
View
K C Pharmaceuticals, Inc
Maxyne Lam
,
Uttaniti Limchumroon
, and
Sonia R. Peterson
Price:
$117.00
View
Recsei Laboratories, LLC
Matthew J. Johnson
and
Sonia R. Peterson
Price:
$117.00
View
View All Products by Sonia R. Peterson
Upcoming Events
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
Risk of 10 Obesity-Driven Cancers Reduced by GLP-1s, Study Says
Three Device Areas Added to CDRH’s Device-Advancing TAP Program
Third Alzheimer’s Drug Gets FDA Approval, Just as Diagnostic Criteria Expand
Draft Guidance Covers Using URRAs in Combo Product Applications
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More